Survival outcome and optimal candidates of primary tumor resection for patients with metastatic medullary thyroid cancer.

PTR may confer therapeutic benefits for carefully selected individuals with metastatic MTCs. To integrate these insights into clinical decision-making settings, it is imperative to undertake multicenter prospective studies in the future.